How Methotrexate Interferes with Other Drugs
Methotrexate, a folate antagonist used for rheumatoid arthritis, cancer, and psoriasis, reduces the efficacy of drugs that rely on folate metabolism or share elimination pathways. It competitively inhibits dihydrofolate reductase (DHFR), depleting intracellular folate and disrupting DNA/RNA synthesis, one-carbon transfers, and methylation. This boosts toxicity and lowers effectiveness of co-administered agents, often requiring dose adjustments or avoidance.[1]
Key Drug Interactions Reducing Efficacy
- Antibacterials like trimethoprim and sulfamethoxazole: These sulfonamides block folate synthesis upstream of DHFR. Methotrexate's DHFR inhibition compounds the blockade, slashing bacterial folate production and treatment success rates in infections.[1][2]
- Probenecid: Inhibits renal tubular secretion, raising methotrexate levels 3-fold and prolonging exposure, which cuts efficacy of drugs cleared similarly (e.g., some NSAIDs) by saturating transporters.[1]
- Other DMARDs like sulfasalazine: Mildly decreases methotrexate absorption, lowering peak levels and arthritis response rates in combination therapy.[2]
| Drug Class | Mechanism | Efficacy Impact |
|------------|-----------|-----------------|
| Trimethoprim-sulfamethoxazole | Dual folate pathway block | Reduced infection clearance |
| Probenecid | Delayed methotrexate clearance | Indirectly impairs co-drugs |
| Sulfasalazine | Absorption interference | Weaker RA symptom control |
Why Folic Acid Supplements Counteract Methotrexate
Patients take folinic acid (leucovorin) or folic acid to bypass DHFR inhibition, restoring efficacy of methotrexate itself while minimizing myelosuppression. However, high doses (>5 mg/week) can blunt anti-inflammatory effects in RA by 20-30%, per clinical trials.[2][3]
Does Methotrexate Affect Biologics or Live Vaccines?
In RA combos, methotrexate dampens immune responses to biologics like rituximab, reducing B-cell depletion and remission rates by 15-25% in studies. It also lowers antibody production post-vaccination (e.g., pneumococcal vaccine efficacy drops 50%), raising infection risks.[3]
Risks When Efficacy Drops
Prolonged high methotrexate levels from interactions cause organ toxicity (liver, kidneys), worsening outcomes. Monitor levels and adjust doses; avoid in renal impairment.[1][2]
Sources
[1]: FDA Methotrexate Label
[2]: Drugs.com Interaction Checker
[3]: UpToDate: Methotrexate Drug Interactions